Literature DB >> 22161250

Prevention of type 2 diabetes: the strategic approach for implementation.

P E H Schwarz1, A L Albright.   

Abstract

A growing need exists to deliver effective and affordable prevention programs and to take urgent action to address the major public health challenge that diabetes represents. Achieving prevention of type 2 diabetes requires moving through a series of steps from basic science discovery to widespread distribution of effective interventions. Understanding the cellular level influences on diabetes prevention will help target particular interventions to those who may be most responsive. Several randomized controlled trials conducted throughout the world have demonstrated that type 2 diabetes can be prevented or delayed. Subsequent real-world translation studies have provided important information necessary to reduce cost and increase access. Ultimately achieving a population impact in diabetes prevention requires widespread distribution of effective interventions, which is supported by policies that help achieve sustainability and reach. The use of a global stakeholder network can help to share experiences and build on partner knowledge gained. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 22161250      PMCID: PMC4556234          DOI: 10.1055/s-0031-1295462

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  29 in total

1.  Implementation and effectiveness of the first community lifestyle intervention programme to prevent Type 2 diabetes in Greece. The DE-PLAN study.

Authors:  K Makrilakis; S Liatis; S Grammatikou; D Perrea; N Katsilambros
Journal:  Diabet Med       Date:  2010-04       Impact factor: 4.359

Review 2.  The Metabolic Syndrome - a global challenge for prevention.

Authors:  P E H Schwarz; M Reimann; J Li; A Bergmann; J Licinio; M-L Wong; S R Bornstein
Journal:  Horm Metab Res       Date:  2007-11       Impact factor: 2.936

3.  Prevalence for the cluster of risk factors of the Metabolic Vascular Syndrome in a working population in Germany.

Authors:  U Rothe; G Müller; S Tselmin; C Odenbach; K Scheuch; R Koch; S Bergmann; M Walter; A Bergmann; S R Bornstein; P E H Schwarz
Journal:  Horm Metab Res       Date:  2008-12-19       Impact factor: 2.936

4.  Physical activity, diet, and incident diabetes in relation to an ADRA2B polymorphism.

Authors:  David E Laaksonen; Niina Siitonen; Jaana Lindström; Johan G Eriksson; Piritta Reunanen; Jaakko Tuomilehto; Matti Uusitupa
Journal:  Med Sci Sports Exerc       Date:  2007-02       Impact factor: 5.411

Review 5.  A clinician's guide to cost-effectiveness analysis.

Authors:  A S Detsky; I G Naglie
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

6.  Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe.

Authors:  J Lindström; A Neumann; K E Sheppard; A Gilis-Januszewska; C J Greaves; U Handke; P Pajunen; S Puhl; A Pölönen; A Rissanen; M Roden; T Stemper; V Telle-Hjellset; J Tuomilehto; D Velickiene; P E Schwarz; T Acosta; M Adler; A AlKerwi; N Barengo; R Barengo; J M Boavida; K Charlesworth; V Christov; B Claussen; X Cos; E Cosson; S Deceukelier; V Dimitrijevic-Sreckovic; P Djordjevic; P Evans; A-M Felton; M Fischer; R Gabriel-Sanchez; A Gilis-Januszewska; M Goldfracht; J L Gomez; C J Greaves; M Hall; U Handke; H Hauner; J Herbst; N Hermanns; L Herrebrugh; C Huber; U Hühmer; J Huttunen; A Jotic; Z Kamenov; S Karadeniz; N Katsilambros; M Khalangot; K Kissimova-Skarbek; D Köhler; V Kopp; P Kronsbein; B Kulzer; D Kyne-Grzebalski; K Lalic; N Lalic; R Landgraf; Y H Lee-Barkey; S Liatis; J Lindström; K Makrilakis; C McIntosh; M McKee; A C Mesquita; D Misina; F Muylle; A Neumann; A C Paiva; P Pajunen; B Paulweber; M Peltonen; L Perrenoud; A Pfeiffer; A Pölönen; S Puhl; F Raposo; T Reinehr; A Rissanen; C Robinson; M Roden; U Rothe; T Saaristo; J Scholl; P E Schwarz; K E Sheppard; S Spiers; T Stemper; B Stratmann; J Szendroedi; Z Szybinski; T Tankova; V Telle-Hjellset; G Terry; D Tolks; F Toti; J Tuomilehto; A Undeutsch; C Valadas; P Valensi; D Velickiene; P Vermunt; R Weiss; J Wens; T Yilmaz
Journal:  Horm Metab Res       Date:  2010-04-13       Impact factor: 2.936

7.  TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.

Authors:  Jose C Florez; Kathleen A Jablonski; Nick Bayley; Toni I Pollin; Paul I W de Bakker; Alan R Shuldiner; William C Knowler; David M Nathan; David Altshuler
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

8.  Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery.

Authors:  M Kaye Kramer; Andrea M Kriska; Elizabeth M Venditti; Rachel G Miller; Maria M Brooks; Lora E Burke; Linda M Siminerio; Francis X Solano; Trevor J Orchard
Journal:  Am J Prev Med       Date:  2009-12       Impact factor: 5.043

9.  Translating the diabetes prevention program into practice in the general community: findings from the Montana Cardiovascular Disease and Diabetes Prevention Program.

Authors:  Helen A Amundson; Marcene K Butcher; Dorothy Gohdes; Taryn O Hall; Todd S Harwell; Steven D Helgerson; Karl K Vanderwood
Journal:  Diabetes Educ       Date:  2009 Mar-Apr       Impact factor: 2.140

10.  Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study.

Authors:  Ronald T Ackermann; Emily A Finch; Edward Brizendine; Honghong Zhou; David G Marrero
Journal:  Am J Prev Med       Date:  2008-10       Impact factor: 5.043

View more
  3 in total

Review 1.  Who should we target for diabetes prevention and diabetes risk reduction?

Authors:  Susann Blüher; Jana Markert; Sabine Herget; Thomas Yates; Melanie Davis; Gabriele Müller; Thomas Waldow; Peter E H Schwarz
Journal:  Curr Diab Rep       Date:  2012-04       Impact factor: 4.810

Review 2.  Is physical exercise a core therapeutical element for most patients with type 2 diabetes?

Authors:  Pierpaolo De Feo; Peter Schwarz
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

3.  Diabetes prevention - the global hope on the horizon.

Authors:  Peter E H Schwarz
Journal:  Indian J Med Res       Date:  2012-11       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.